NCT01176578View on ClinicalTrials.gov

Exercise Endothelial Progenitor Cells (EPCs) and Type 2 Diabetes

NAActive, not recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2026

Conditions
Type 2 Diabetes Mellitus
Interventions
OTHER

Aerobic Exercise Training

6 months of aerobic exercise training, 3 days per week

Trial Locations (1)

21201

Baltimore VA Medical Center, Baltimore

All Listed Sponsors
collaborator

University of Maryland, Baltimore

OTHER

lead

Baltimore VA Medical Center

FED